Neutral glycolipids of atherosclerotic plaques and unaffected human aorta tissue
The composition, structure and localization of neutral glycosphingolipids of human aorta taken from subjects who had died after myocardial infarction were studied. Individual glycosphingolipids were purified by high‐performance liquid chromatography and were characterized on the basis of their chrom...
Saved in:
Published in | European journal of biochemistry Vol. 180; no. 1; pp. 167 - 171 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.03.1989
Blackwell |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The composition, structure and localization of neutral glycosphingolipids of human aorta taken from subjects who had died after myocardial infarction were studied. Individual glycosphingolipids were purified by high‐performance liquid chromatography and were characterized on the basis of their chromatographic mobility, carbohydrate composition, methylation analysis and by 1H‐NMR spectroscopy. The main aortic glycosphingolipids were identified as glucosylceramide, lactosylceramide, globotriaosylceramide and globotetraosylceramide. Significant differences in the neutral glycosphingolipid composition of intima and media were detected.
The neutral glycosphingolipid profile of medial plaques resembled that of unaffected media; however, significant differences were detected between intimal plaques and unaffected intima. Whereas the latter contained trihexosylceramide and globoside as the only neutral glycolipids, the intimal plaque glycolipids consisted mainly of glucosylceramide and also contained appreciable amounts of lactosylceramide which were completely absent in the unaffected intima. In comparison to intimal plaques, unaffected intima is characterized by a much higher content of cerebrosides terminating by β‐galactosyl residues which are known to interact with growth factors and other external stimuli.
It thus seems possible that the proliferative activity of smooth muscle cells in atherosclerotic diseases is to some extent associated with their neutral glycolipid profile. |
---|---|
AbstractList | The composition, structure and localization of neutral glycosphingolipids of human aorta taken from subjects who had died after myocardial infarction were studied. Individual glycosphingolipids were purified by high-performance liquid chromatography and were characterized on the basis of their chromatographic mobility, carbohydrate composition, methylation analysis and by 1H-NMR spectroscopy. The main aortic glycosphingolipids were identified as glucosylceramide, lactosylceramide, globotriaosylceramide and globotetraosylceramide. Significant differences in the neutral glycosphingolipid composition of intima and media were detected. The neutral glycosphingolipid profile of medial plaques resembled that of unaffected media; however, significant differences were detected between intimal plaques and unaffected intima. Whereas the latter contained trihexosylceramide and globoside as the only neutral glycolipids, the intimal plaque glycolipids consisted mainly of glucosylceramide and also contained appreciable amounts of lactosylceramide which were completely absent in the unaffected intima. In comparison to intimal plaques, unaffected intima is characterized by a much higher content of cerebrosides terminating by beta-galactosyl residues which are known to interact with growth factors and other external stimuli. It thus seems possible that the proliferative activity of smooth muscle cells in atherosclerotic diseases is to some extent associated with their neutral glycolipid profile. The composition, structure and localization of neutral glycosphingolipids of human aorta taken from subjects who had died after myocardial infarction were studied. Individual glycosphingolipids were purified by high‐performance liquid chromatography and were characterized on the basis of their chromatographic mobility, carbohydrate composition, methylation analysis and by 1 H‐NMR spectroscopy. The main aortic glycosphingolipids were identified as glucosylceramide, lactosylceramide, globotriaosylceramide and globotetraosylceramide. Significant differences in the neutral glycosphingolipid composition of intima and media were detected. The neutral glycosphingolipid profile of medial plaques resembled that of unaffected media; however, significant differences were detected between intimal plaques and unaffected intima. Whereas the latter contained trihexosylceramide and globoside as the only neutral glycolipids, the intimal plaque glycolipids consisted mainly of glucosylceramide and also contained appreciable amounts of lactosylceramide which were completely absent in the unaffected intima. In comparison to intimal plaques, unaffected intima is characterized by a much higher content of cerebrosides terminating by β‐galactosyl residues which are known to interact with growth factors and other external stimuli. It thus seems possible that the proliferative activity of smooth muscle cells in atherosclerotic diseases is to some extent associated with their neutral glycolipid profile. The composition, structure and localization of neutral glycosphingolipids of human aorta taken from subjects who had died after myocardial infarction were studied. Individual glycosphingolipids were purified by high‐performance liquid chromatography and were characterized on the basis of their chromatographic mobility, carbohydrate composition, methylation analysis and by 1H‐NMR spectroscopy. The main aortic glycosphingolipids were identified as glucosylceramide, lactosylceramide, globotriaosylceramide and globotetraosylceramide. Significant differences in the neutral glycosphingolipid composition of intima and media were detected. The neutral glycosphingolipid profile of medial plaques resembled that of unaffected media; however, significant differences were detected between intimal plaques and unaffected intima. Whereas the latter contained trihexosylceramide and globoside as the only neutral glycolipids, the intimal plaque glycolipids consisted mainly of glucosylceramide and also contained appreciable amounts of lactosylceramide which were completely absent in the unaffected intima. In comparison to intimal plaques, unaffected intima is characterized by a much higher content of cerebrosides terminating by β‐galactosyl residues which are known to interact with growth factors and other external stimuli. It thus seems possible that the proliferative activity of smooth muscle cells in atherosclerotic diseases is to some extent associated with their neutral glycolipid profile. The composition, structure and localization of neutral glycosphingolipids of human aorta taken from subjects who had died after myocardial infarction were studied. Individual glycosphingolipids were purified by high-performance liquid chromatography and were characterized on the basis of their chromatographic mobility, carbohydrate composition, methylation analysis and by super(1)H-NMR spectroscopy. The main aortic glycosphingolipids were identified as glucosylceramide, lactosylceramide, globotriaosylceramide and globotetraosylceramide. The composition, structure and localization of neutral glycosphingolipids of human aorta taken from subjects who had died after myocardial infarction were studied. Individual glycosphingolipids were purified by high-performance liquid chromatography and were characterized on the basis of their chromatographic mobility, carbohydrate composition, methylation analysis and by 1H-NMR spectroscopy. The main aortic glycosphingolipids were identified as glucosylceramide, lactosylceramide, globotriaosylceramide and globotetraosylceramide. Significant differences in the neutral glycosphingolipid composition of intima and media were detected. The neutral glycosphingolipid profile of medial plaques resembled that of unaffected media; however, significant differences were detected between intimal plaques and unaffected intima. Whereas the latter contained trihexosylceramide and globoside as the only neutral glycolipids, the intimal plaque glycolipids consisted mainly of glucosylceramide and also contained appreciable amounts of lactosylceramide which were completely absent in the unaffected intima. In comparison to intimal plaques, unaffected intima is characterized by a much higher content of cerebrosides terminating by beta-galactosyl residues which are known to interact with growth factors and other external stimuli. It thus seems possible that the proliferative activity of smooth muscle cells in atherosclerotic diseases is to some extent associated with their neutral glycolipid profile.The composition, structure and localization of neutral glycosphingolipids of human aorta taken from subjects who had died after myocardial infarction were studied. Individual glycosphingolipids were purified by high-performance liquid chromatography and were characterized on the basis of their chromatographic mobility, carbohydrate composition, methylation analysis and by 1H-NMR spectroscopy. The main aortic glycosphingolipids were identified as glucosylceramide, lactosylceramide, globotriaosylceramide and globotetraosylceramide. Significant differences in the neutral glycosphingolipid composition of intima and media were detected. The neutral glycosphingolipid profile of medial plaques resembled that of unaffected media; however, significant differences were detected between intimal plaques and unaffected intima. Whereas the latter contained trihexosylceramide and globoside as the only neutral glycolipids, the intimal plaque glycolipids consisted mainly of glucosylceramide and also contained appreciable amounts of lactosylceramide which were completely absent in the unaffected intima. In comparison to intimal plaques, unaffected intima is characterized by a much higher content of cerebrosides terminating by beta-galactosyl residues which are known to interact with growth factors and other external stimuli. It thus seems possible that the proliferative activity of smooth muscle cells in atherosclerotic diseases is to some extent associated with their neutral glycolipid profile. |
Author | GLADKAYA, Elena M. MUKHIN, Dmitry N. VASILEVSKAYA, Valentina V. BUSHUEV, Valery N. OREKHOV, Alexander N. BERGELSON, Lev D. MIKHAILENKO, Irina A. SADOVSKAYA, Valentina L. PROKAZOVA, Nina V. |
Author_xml | – sequence: 1 givenname: Nina V. surname: PROKAZOVA fullname: PROKAZOVA, Nina V. – sequence: 2 givenname: Dmitry N. surname: MUKHIN fullname: MUKHIN, Dmitry N. – sequence: 3 givenname: Alexander N. surname: OREKHOV fullname: OREKHOV, Alexander N. – sequence: 4 givenname: Elena M. surname: GLADKAYA fullname: GLADKAYA, Elena M. – sequence: 5 givenname: Valentina V. surname: VASILEVSKAYA fullname: VASILEVSKAYA, Valentina V. – sequence: 6 givenname: Irina A. surname: MIKHAILENKO fullname: MIKHAILENKO, Irina A. – sequence: 7 givenname: Valentina L. surname: SADOVSKAYA fullname: SADOVSKAYA, Valentina L. – sequence: 8 givenname: Valery N. surname: BUSHUEV fullname: BUSHUEV, Valery N. – sequence: 9 givenname: Lev D. surname: BERGELSON fullname: BERGELSON, Lev D. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7262440$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/2707259$$D View this record in MEDLINE/PubMed |
BookMark | eNqVkUtv1DAUhS1UVKaFn4BkIcQuwc_YZsOjagGpAiRgbd04NvXIk0xjR3T-PYkmdMEG8MJenO_ca51zhk76ofcIPaOkpvN5ua2p4KyihPOaGm3q0lLRMF3fPUCbe-kEbQihomJGNo_QWc5bQkhjGnWKTpkiikmzQV8--amMkPCPdHBDivvYZTwEDOXGj0N2ab5LdHif4HbyGUPf4amHELwrvsM30w56DMNYAJeY8-Qfo4cBUvZP1vccfb-6_Hbxobr-_P7jxdvrygnNVNVq11LVSUa196wFANkFExjrGglCBUM77agwkgeuBShNhPC6NablQs8kP0cvjnP347D8rNhdzM6nBL0fpmyVNlxqov4KUsk0kbqZwacrOLU739n9GHcwHuya1aw_X3XIDlIYoXcx32OKNUwIMmNvjpib88ujD9bFAiUO_ZxzTJYSu5Rot3Zpyi5N2aVEu5Zo7-YRr_4Y8XvJP5lfH80_Y_KH_3Daq8t3X2mj-C_apLbO |
CODEN | EJBCAI |
CitedBy_id | crossref_primary_10_1016_0021_9150_92_90253_D crossref_primary_10_1007_s00428_005_1246_y crossref_primary_10_1016_j_atherosclerosis_2017_11_034 crossref_primary_10_1016_0021_9150_92_90235_9 crossref_primary_10_1161_01_ATV_15_10_1607 crossref_primary_10_1007_BF02537083 crossref_primary_10_1016_j_atherosclerosis_2007_09_018 crossref_primary_10_1016_0006_291X_91_91225_2 |
Cites_doi | 10.1007/BF01108615 10.1111/j.1432-1033.1977.tb11778.x 10.1146/annurev.bi.50.070181.003505 10.1007/BF02533559 10.1016/0009-3084(74)90055-3 10.1016/0167-4889(88)90004-3 10.1139/v81-111 10.1159/000145868 10.1515/bchm2.1973.354.1.21 10.1038/325574a0 10.1111/j.1432-1033.1987.tb13343.x 10.4049/jimmunol.133.2.835 10.1021/bi00565a030 10.1016/0003-9861(87)90600-X 10.1042/bj2150261 10.1016/S0021-9258(18)32304-4 |
ContentType | Journal Article |
Copyright | 1989 INIST-CNRS |
Copyright_xml | – notice: 1989 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 8FD FR3 M7Z P64 7X8 |
DOI | 10.1111/j.1432-1033.1989.tb14628.x |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Technology Research Database Engineering Research Database Biochemistry Abstracts 1 Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Biochemistry Abstracts 1 Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Biochemistry Abstracts 1 MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Chemistry |
EISSN | 1432-1033 |
EndPage | 171 |
ExternalDocumentID | 2707259 7262440 10_1111_j_1432_1033_1989_tb14628_x FEBS167 |
Genre | article Journal Article |
GroupedDBID | -DZ -~X .55 .GA .GJ .Y3 10A 1OC 24P 29G 31~ 36B 3O- 4.4 51W 51X 52N 52O 52P 52R 52S 52T 52W 52X 53G 5GY 5HH 5LA 5RE 66C 7PT 8-1 8-4 8-5 930 A01 A03 AAEVG AAHHS AAZKR ABDBF ABDPE ABEFU ABJNI ACCFJ ACFBH ACGFS ACMXC ACNCT ACUHS ACXQS ADBBV ADIZJ ADZOD AEEZP AEIMD AEQDE AEUQT AFBPY AFPWT AFZJQ AI. AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR BAWUL BY8 C45 CAG CO8 COF CS3 D-7 D-F DIK E3Z EAD EAP EAS EAU EBB EBC EBD EBS EBX EJD EMB EMK EMOBN EST ESX EX3 F00 F01 F04 F5P G-S GODZA GX1 HZI IH2 IHE IPNFZ L7B LH4 LP6 LP7 LW6 MVM O9- OBS OHT OVD P4B P4D QB0 RIG ROL SDH SUPJJ SV3 TEORI TR2 TUS UB1 VH1 WH7 WOW WQJ WRC WXI X7M XG1 Y6R YFH YSK YUY ZGI ZXP AAYXX ADXHL AETEA CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY IQODW CGR CUY CVF ECM EIF NPM PKN 8FD FR3 M7Z P64 7X8 |
ID | FETCH-LOGICAL-c4827-b8cb17d5218ee2baaa5df9f22d65a47f91d8c14953f384a78044e8b99b348df93 |
IEDL.DBID | 24P |
ISSN | 0014-2956 |
IngestDate | Fri Jul 11 02:41:05 EDT 2025 Fri Jul 11 08:58:52 EDT 2025 Wed Feb 19 02:34:19 EST 2025 Mon Jul 21 09:12:26 EDT 2025 Tue Jul 01 02:34:36 EDT 2025 Thu Apr 24 23:07:55 EDT 2025 Wed Jan 22 16:49:24 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Human Atherosclerosis Aorta Cardiovascular disease Aortic disease Glycolipid Plate |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4827-b8cb17d5218ee2baaa5df9f22d65a47f91d8c14953f384a78044e8b99b348df93 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1432-1033.1989.tb14628.x |
PMID | 2707259 |
PQID | 15280586 |
PQPubID | 23462 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_78935807 proquest_miscellaneous_15280586 pubmed_primary_2707259 pascalfrancis_primary_7262440 crossref_citationtrail_10_1111_j_1432_1033_1989_tb14628_x crossref_primary_10_1111_j_1432_1033_1989_tb14628_x wiley_primary_10_1111_j_1432_1033_1989_tb14628_x_FEBS167 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | March 1989 |
PublicationDateYYYYMMDD | 1989-03-01 |
PublicationDate_xml | – month: 03 year: 1989 text: March 1989 |
PublicationDecade | 1980 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: Oxford – name: England |
PublicationTitle | European journal of biochemistry |
PublicationTitleAlternate | Eur J Biochem |
PublicationYear | 1989 |
Publisher | Blackwell Publishing Ltd Blackwell |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
References | 1983; 215 1983; 258 1987; 167 1974; 12 1987; 256 1980; 19 1979; 14 1987; 325 1973; 35 1986; 3 1984; 10 1984; 33 1984; 79 1984; 115 1981; 46 1964; 55 1984; 119 1981; 59 1977; 79 1980 1981; 50 1988; 968 1989 1977; 81 e_1_2_2_3_2 e_1_2_2_24_2 e_1_2_2_23_2 e_1_2_2_5_2 e_1_2_2_22_2 e_1_2_2_21_2 e_1_2_2_20_2 e_1_2_2_2_2 Dyatlovitskaya E. V. (e_1_2_2_11_2) 1981; 46 e_1_2_2_19_2 e_1_2_2_18_2 e_1_2_2_7_2 e_1_2_2_16_2 e_1_2_2_15_2 Dyatlovitskaya E. V. (e_1_2_2_8_2) 1980 e_1_2_2_14_2 e_1_2_2_25_2 Prokazova N. V. (e_1_2_2_12_2) 1984; 10 Kavamura N. (e_1_2_2_9_2) 1977; 81 Orekhov A. N. (e_1_2_2_6_2) 1984; 115 Hakomori S.‐I. (e_1_2_2_13_2) 1964; 55 Wissler R. W. (e_1_2_2_4_2) 1984; 79 Urdal D. L. (e_1_2_2_17_2) 1983; 258 Okada Y. (e_1_2_2_10_2) 1984; 33 |
References_xml | – volume: 33 start-page: 835 year: 1984 end-page: 842 publication-title: J. Immunol. – volume: 55 start-page: 205 year: 1964 end-page: 208 publication-title: J. Biochem. (Tokyo) – volume: 14 start-page: 9 year: 1979 end-page: 14 publication-title: Lipids – volume: 115 start-page: 17 year: 1984 end-page: 24 publication-title: Am. J. Pathol. – volume: 258 start-page: 6869 year: 1983 end-page: 6874 publication-title: J. Biol. Chem. – volume: 325 start-page: 574 year: 1987 end-page: 575 publication-title: Nature (Lond.) – volume: 968 start-page: 167 year: 1988 end-page: 171 publication-title: Biochim. Biophys. Acta – start-page: 244 year: 1980 – volume: 59 start-page: 412 year: 1981 end-page: 417 publication-title: Can. J. Biochem. – volume: 81 start-page: 1217 year: 1977 end-page: 1225 publication-title: J. Biochem. (Tokyo) – year: 1989 – volume: 215 start-page: 261 year: 1983 end-page: 272 publication-title: Biochem. J. – volume: 79 start-page: 11 year: 1977 end-page: 12 publication-title: Eur. J. Biochem. – volume: 19 start-page: 5652 year: 1980 end-page: 5658 publication-title: Biochemistry – volume: 12 start-page: 271 year: 1974 end-page: 284 publication-title: Chem. Phys. Lipids – volume: 3 start-page: 95 year: 1986 end-page: 108 publication-title: Glycoconjugate J. – volume: 256 start-page: 435 year: 1987 end-page: 445 publication-title: Arch. Biochem. Biophys. – volume: 50 start-page: 733 year: 1981 end-page: 764 publication-title: Annu. Rev. Biochem. – volume: 10 start-page: 238 year: 1984 end-page: 243 publication-title: Bioorg. Khim. – volume: 46 start-page: 2004 year: 1981 end-page: 2010 publication-title: Biokhimia – volume: 79 start-page: 5 year: 1984 end-page: 20 publication-title: NATO Adv. Study Inst. Ser. Ser. A, Life Sci. – volume: 119 start-page: 99 year: 1984 end-page: 105 publication-title: Acta Anat. – volume: 35 start-page: 21 year: 1973 end-page: 31 publication-title: Hoppe-Seyler's Z. Physiol. Chem. B. – volume: 167 start-page: 349 year: 1987 end-page: 352 publication-title: Eur. J. Biochem. – ident: e_1_2_2_2_2 doi: 10.1007/BF01108615 – volume: 46 start-page: 2004 year: 1981 ident: e_1_2_2_11_2 publication-title: Biokhimia – ident: e_1_2_2_25_2 doi: 10.1111/j.1432-1033.1977.tb11778.x – ident: e_1_2_2_3_2 doi: 10.1146/annurev.bi.50.070181.003505 – volume: 79 start-page: 5 year: 1984 ident: e_1_2_2_4_2 publication-title: NATO Adv. Study Inst. Ser. Ser. A, Life Sci. – ident: e_1_2_2_20_2 doi: 10.1007/BF02533559 – ident: e_1_2_2_18_2 doi: 10.1016/0009-3084(74)90055-3 – ident: e_1_2_2_24_2 doi: 10.1016/0167-4889(88)90004-3 – volume: 81 start-page: 1217 year: 1977 ident: e_1_2_2_9_2 publication-title: J. Biochem. (Tokyo) – ident: e_1_2_2_19_2 doi: 10.1139/v81-111 – ident: e_1_2_2_7_2 doi: 10.1159/000145868 – volume: 10 start-page: 238 year: 1984 ident: e_1_2_2_12_2 publication-title: Bioorg. Khim. – ident: e_1_2_2_15_2 doi: 10.1515/bchm2.1973.354.1.21 – start-page: 244 volume-title: Lipid biochemical preparations year: 1980 ident: e_1_2_2_8_2 – ident: e_1_2_2_21_2 doi: 10.1038/325574a0 – ident: e_1_2_2_5_2 doi: 10.1111/j.1432-1033.1987.tb13343.x – volume: 33 start-page: 835 year: 1984 ident: e_1_2_2_10_2 publication-title: J. Immunol. doi: 10.4049/jimmunol.133.2.835 – volume: 115 start-page: 17 year: 1984 ident: e_1_2_2_6_2 publication-title: Am. J. Pathol. – ident: e_1_2_2_16_2 doi: 10.1021/bi00565a030 – ident: e_1_2_2_22_2 doi: 10.1016/0003-9861(87)90600-X – ident: e_1_2_2_14_2 doi: 10.1042/bj2150261 – volume: 55 start-page: 205 year: 1964 ident: e_1_2_2_13_2 publication-title: J. Biochem. (Tokyo) – volume: 258 start-page: 6869 year: 1983 ident: e_1_2_2_17_2 publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)32304-4 – ident: e_1_2_2_23_2 |
SSID | ssj0006967 |
Score | 1.4042505 |
Snippet | The composition, structure and localization of neutral glycosphingolipids of human aorta taken from subjects who had died after myocardial infarction were... |
SourceID | proquest pubmed pascalfrancis crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 167 |
SubjectTerms | Adult Antigens, CD aorta Aorta, Thoracic - metabolism Arteriosclerosis - complications Arteriosclerosis - metabolism Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Chromatography, High Pressure Liquid Chromatography, Thin Layer Fatty Acids - analysis Female Globosides - analysis glycolipids Glycolipids - analysis Glycosphingolipids - analysis Humans Lactosylceramides Magnetic Resonance Spectroscopy Male Mass Spectrometry Medical sciences Middle Aged Muscle, Smooth, Vascular - metabolism Myocardial Infarction - complications Myocardial Infarction - metabolism |
Title | Neutral glycolipids of atherosclerotic plaques and unaffected human aorta tissue |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1432-1033.1989.tb14628.x https://www.ncbi.nlm.nih.gov/pubmed/2707259 https://www.proquest.com/docview/15280586 https://www.proquest.com/docview/78935807 |
Volume | 180 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEA9SHxREtLW41moexLc9bpNsPh7b0qMIloIW-hbytVI4d4_uHdj_3pns3uKJBfU9M4RMZvJLMvMbQj7E2AQdXCqrEFkpQuVLw5wvhfZ1UADImcZq5M-X8uJafLqpb8byaKyFGfghpgc39Iwcr9HBne9_c3LOIIxwPsPEn9naV1hoOQNE-RhrbZFJn4mrKS5LIwcGzUqUDGYxUpCOeT0P6No5rp6tXA8r1wwtL_6ESXchbj6jFi_I8xFc0pNhN7wkj1K7Tw5OWrhYf7-nH2lO98zv6Pvkydm21dsBubpMG3zxoN-W97Axble3saddQzM67HrQddeBSrpaOpwIdW2km9blVJAUae7zRx0CebrOhnxFrhfnX88uyrHVQhmQB7T0OvhKRTjLdUrMO-fq2JiGsShrJ1RjqqhDzkVtuBYOWYtE0t4Yz4WGkfyQ7LVdm14T6jUzDKKW9CwKr5MDEBCDNDylCvSwgpjtitow8pBjO4yl_fU-wplFa1i0hh2tYX8UhE-yq4GN46-kjncMN4kqJgHdzAvyfmtICwuPPyauTd2mtwBu9LzW8uERSuePZFWQw2EHTMqZmiu4WxZE5x3xD_O1i_PTL5VUb_5f9Ig8HZLhMFnuLdlb323SMaCntX-XneInJZAOJA |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxwxEB_EPlgoxWqlW7XmofRtj9tsNsk-qnhcW-8QquBbyNcW4dw9vDuo_30n2b2lJwpt3_KQGULmI79MJjMAn52rrLTap5l1NGU2M2lJtUmZNIUVCMipDL-RJ1M-vmHfbovbLZis_8K09SH6gFuwjOivg4GHgPQTK88p-pE8H4TMn8HSZOGn5QAh5SsciGCnlF31jpmXvC2hmbGU4jK6GqRdYs8LvDbOqzdzvcCtq9qeF8-B0k2MGw-p0S687dAlOW3V4R1s-XoP9k9rvFnfP5IvJOZ7xkD6Huycr3u97cPV1K9CyIP8nD2iZtzN79yCNBWJ8LBZIK-HBlmS-UyHhRBdO7KqdcwF8Y7ERn9EByRPllGS7-FmdHF9Pk67XgupDYVAUyOtyYTDw1x6T43WunBVWVHqeKGZqMrMSRuTUatcMh3KFjEvTVmanEmcmR_Adt3U_gMQI2lJ0W1xQx0z0mtEAc7yMvc-Qz40gXK9o8p2hchDP4yZ-vNCklMVpKGCNFQnDfUrgbynnbflOP6K6nhDcD2poBzhzTCBk7UgFW58eDLRtW9WC4XoRg4LyV-eIWR8SRYJHLQa0DOnYijwcpmAjBrxD-tVo4uzHxkXH_-f9AR2xteTS3X5dfr9EF63mXEhc-4ItpcPK3-MUGppPkUD-Q2-hhGQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEB-kggoi2lpctTYP4tset0l2kzzW2qN-HQda6FvI10rh3F16d2D_eyfZvcUTC-p7ZgiZzOSXZOY3AK-9r510JuSF8zTnrrC5osbmXNrSCQTkVMZq5M_z6vyCf7gsL4fy6FgL0_NDjA9u0TNSvI4O3vn6NydnFMMIY5OY-DNZ2yIWWk4QUd5Nv3-R55kvxrhcqapn0Cx4TnEWAwXpkNdzi66d4-phZ1a4cnXf8uJPmHQX4qYzavYYHg3gkpz0u-EJ3AnNPhycNHix_n5D3pCU7pne0ffh_um21dsBLOZhE188yLflDW6Mq-7Kr0hbk4QO2xXqum5RJemWJk6EmMaTTWNSKkjwJPX5IyYCebJOhnwKF7Ozr6fn-dBqIXeRBzS30tlCeDzLZQjUGmNKX6uaUl-VhotaFV66lItaM8lNZC3iQVqlLOMSR7JD2GvaJjwDYiVVFKNWZannVgaDIMC7SrEQCtRDM1DbFdVu4CGP7TCW-tf7CKM6WkNHa-jBGvpHBmyU7Xo2jr-SOtox3CgqaIXoZprB8daQGhc-_piYJrSblUZwI6elrG4fIWT6SBYZHPY7YFROxVTg3TIDmXbEP8xXz87efikq8fz_RY_h3uLdTH96P__4Ah70eXExb-4l7K2vN-EIgdTavkr-8RMN9xDC |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neutral+glycolipids+of+atherosclerotic+plaques+and+unaffected+human+aorta+tissue&rft.jtitle=European+journal+of+biochemistry&rft.au=PROKAZOVA%2C+Nina+V.&rft.au=MUKHIN%2C+Dmitry+N.&rft.au=OREKHOV%2C+Alexander+N.&rft.au=GLADKAYA%2C+Elena+M.&rft.date=1989-03-01&rft.issn=0014-2956&rft.eissn=1432-1033&rft.volume=180&rft.issue=1&rft.spage=167&rft.epage=171&rft_id=info:doi/10.1111%2Fj.1432-1033.1989.tb14628.x&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_j_1432_1033_1989_tb14628_x |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0014-2956&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0014-2956&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0014-2956&client=summon |